Literature DB >> 12196561

Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes.

Tatyana I Gudz1, Tracy E Schneider, Thomas A Haas, Wendy B Macklin.   

Abstract

Myelination of axons in the CNS by oligodendrocytes is a process critical to rapid and efficient impulse conduction. A new role for the myelin proteolipid protein (PLP), the most abundant protein of CNS myelin, has been identified, in studies showing PLP interaction with signaling proteins in oligodendrocytes. In particular, these studies suggest that the PLP protein may be involved in signaling through integrins in oligodendrocytes. Stimulation of muscarinic acetylcholine receptors on oligodendrocytes induced formation of a tripartite complex containing PLP, calreticulin, and alpha(v)-integrin. PLP interacted directly with the cytoplasmic domain of the alpha(v)-integrin. Complex formation was mediated by phospholipase C and Ca2+ binding to the high affinity binding site on calreticulin. This complex appears important for binding of fibronectin to oligodendrocytes. These data establish a novel function for PLP as a part of the integrin signaling complex in oligodendrocytes and suggest that neurotransmitter-mediated integrin receptor signaling may be involved in myelinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196561      PMCID: PMC6757967     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

Review 1.  The unfolded protein response in protein aggregating diseases.

Authors:  Alexander Gow; Ramaswamy Sharma
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

Review 2.  White matter rafting--membrane microdomains in myelin.

Authors:  Lillian S Debruin; George Harauz
Journal:  Neurochem Res       Date:  2006-09-21       Impact factor: 3.996

3.  Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.

Authors:  Stephanie A Amici; William A Dunn; Andrew J Murphy; Niels C Adams; Nicholas W Gale; David M Valenzuela; George D Yancopoulos; Lucia Notterpek
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 4.  Features and functions of oligodendrocytes and myelin proteins of lower vertebrate species.

Authors:  Gunnar Jeserich; Katrin Klempahn; Melanie Pfeiffer
Journal:  J Mol Neurosci       Date:  2008-02-26       Impact factor: 3.444

5.  The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination.

Authors:  K Kucharova; W B Stallcup
Journal:  Neuroscience       Date:  2009-12-16       Impact factor: 3.590

6.  Expression of proteolipid protein gene in spinal cord stem cells and early oligodendrocyte progenitor cells is dispensable for normal cell migration and myelination.

Authors:  Danielle E Harlow; Katherine E Saul; Cecilia M Culp; Elisa M Vesely; Wendy B Macklin
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

7.  The QKI-PLP pathway controls SIRT2 abundance in CNS myelin.

Authors:  H Zhu; L Zhao; E Wang; N Dimova; G Liu; Y Feng; F Cambi
Journal:  Glia       Date:  2011-09-21       Impact factor: 7.452

8.  Glial M6B stabilizes the axonal membrane at peripheral nodes of Ranvier.

Authors:  Marie L Bang; Anya Vainshtein; Hyun-Jeong Yang; Yael Eshed-Eisenbach; Jerome Devaux; Hauke B Werner; Elior Peles
Journal:  Glia       Date:  2017-12-28       Impact factor: 7.452

9.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

Review 10.  The multiple roles of myelin protein genes during the development of the oligodendrocyte.

Authors:  Daniel Fulton; Pablo M Paez; Anthony T Campagnoni
Journal:  ASN Neuro       Date:  2010-02-01       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.